Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Use this RARE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RARE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RARE SEC filings page. Lician reads the product cache first so this HTML stays unique to Ultragenyx even when a live quote feed is slow.
Latest cached year on this hub. Full RARE income, balance, and cash tables.